Wednesday, December 24, 2025
ADVT 
National

First molecular image of COVID-19 variant released

Darpan News Desk The Canadian Press, 04 May, 2021 12:41 AM
  • First molecular image of COVID-19 variant released

The first images of a mutation on a COVID-19 variant of concern have been captured by researchers at the University of British Columbia who say the photos offer some reassurance about how the virus strain may react to current vaccines.

The University of B.C. says the researchers are the first to publish structural images of the mutation found on one portion of the SARS-CoV-2 spike protein.

The spike protein is the part of the virus that opens the door to infection, while the mutation is the change believed partly responsible for the rapid spread of the variant first identified in the United Kingdom.

A team led by Dr. Sriram Subramaniam, professor in the department of biochemistry and molecular biology at UBC's faculty of medicine, found the images show localized placement of the mutation allows it to enter human cells more easily.

The team's analysis, recently published in PLOS Biology, reveals that, once inside, the mutation can still be sidelined by antibodies from current vaccines.

Researchers say that adds to growing evidence that most antibodies generated by existing vaccines are likely to remain effective in preventing mild and severe cases of the B.1.1.7 variant.

The statement says its researchers are also using beams of supercooled electrons in powerful microscopes to visualize the detailed shapes of other COVID-19 variants that are 100,000 times smaller than a pinhead.

"It’s important to understand the different molecular structures of these emerging variants to determine whether they’ll respond to existing treatments and vaccines and ultimately find ways to control their spread more effectively," the statement says.

Variants under study at UBC include those first identified in India, California and South Africa, as well as the P.1 variant of concern first found in Brazil, which along with the B.1.1.7 mutation has accounted for a growing number of infections in Canada.

MORE National ARTICLES

Trudeau Government Extends Wage and Rent Subsidy Amounts Through to June

Trudeau Government Extends Wage and Rent Subsidy Amounts Through to June
Today, the Deputy Prime Minister and Minister of Finance, the Honourable Chrystia Freeland, announced that the government intends to extend the current rate structures for these subsidies from March 14 to June 5, 2021.

Trudeau Government Extends Wage and Rent Subsidy Amounts Through to June

Kielburgers refuse request to testify

Kielburgers refuse request to testify
In a statement, the charity notes that New Democrat MP Charlie Angus has requested that the RCMP and the Canada Revenue Agency investigate WE's operations.

Kielburgers refuse request to testify

U.K., Israel studies show single dose effective

U.K., Israel studies show single dose effective
B.C. provincial health officer Dr. Bonnie Henry has said the plan is based on research in the two countries as well as evidence collected by the BC Centre for Disease Control and in Quebec.

U.K., Israel studies show single dose effective

Ex-ombud says he told Sajjan about Vance in 2018

Ex-ombud says he told Sajjan about Vance in 2018
Sajjan at that time repeatedly refused to say what he and Walbourne discussed during their meeting on March 1, 2018, citing confidentiality.

Ex-ombud says he told Sajjan about Vance in 2018

Trump words on Meng a 'salvo' in trade war: lawyer

Trump words on Meng a 'salvo' in trade war: lawyer
Meng was arrested at Vancouver's airport on Dec. 1, 2018, at the request of U.S. officials on charges of fraud that both she and Huawei deny.

Trump words on Meng a 'salvo' in trade war: lawyer

Ottawa budgets $5B to buy COVID-19 pharmaceuticals

Ottawa budgets $5B to buy COVID-19 pharmaceuticals
Canada is guaranteed to buy more than 240 million doses of seven different vaccines if all are approved, with only 6.5 million doses expected before the end of March.

Ottawa budgets $5B to buy COVID-19 pharmaceuticals